UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027628
Receipt number R000031656
Scientific Title Prospective evaluation of patient state index using different versions of Sedline
Date of disclosure of the study information 2017/06/05
Last modified on 2021/11/29 08:22:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective evaluation of patient state index using different versions of Sedline

Acronym

Patient state index in different versions of SedLine

Scientific Title

Prospective evaluation of patient state index using different versions of Sedline

Scientific Title:Acronym

Patient state index in different versions of SedLine

Region

Japan


Condition

Condition

Unspecified diseases which require general anesthesia during surgery

Classification by specialty

Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the difference in patient state index values between different versions of SedLine

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To compare the duration in which PSI values > 50 between different versions of SedLine when anesthesia is titrated so that BIS values around 50

Key secondary outcomes

PSI and BIS values, degree of sedation, and EEG waveforms at that time.
Patient's basic information (age, height, weight, gender, ASA; anesthesia risk classification according to the patient's health condition, and the nature of surgery)
Patient complications (history and treatment of hypertension, diabetes mellitus, chronic renal failure, and ischemic heart disease)
The following time-varying data will be recorded in the anesthesia chart or on the equipment used throughout the anesthesia management. Transcribe or download after completion.
Exhaled inhalant anesthetic concentration, heart rate, blood pressure, blood oxygen saturation (SpO2), body temperature, partial pressure of exhaled carbon dioxide, heart rate variability, perfusion index, SR/SUP (an index reflecting the suppression of EEG by deep anesthesia), EMG (an index reflecting the degree of EMG mixed with EEG), SEF, SEF_L, SEF_R (EEG) SEF, SEF_L, SEF_R (indices reflecting the depth of sedation based on EEG analysis), TP (indices reflecting the magnitude of EEG based on EEG analysis), ARTIFACT and SQI (indices indicating the reliability of the obtained EEG indices), BIS (sedation indices obtained from EEG analysis), doses and concentrations of intravenous anesthetics used (propofol, fentanyl, PSI (sedation index obtained from EEG analysis), EEG data over time and power spectrum data.
These indicators will be analyzed cross-sectionally.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

During anesthesia, the older SedLine version is used

Interventions/Control_2

During anesthesia, the newer SedLine version is used

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who are scheduled to undergo elective surgery which require general anesthesia and tracheal intubation and provided written informed consent whose physical status in American Society of Anesthesiologists classification I or II.

Key exclusion criteria

Exclusion criteria includes known allergy to propofol; psychoneurotic disorders; psychiatric pharmacotherapy; chronic use of opioids; cirrhosis; and those who were considered inadequate.

Target sample size

36


Research contact person

Name of lead principal investigator

1st name Murakawa
Middle name
Last name Masahiro

Organization

Fukushima Medical University

Division name

Anesthesiology

Zip code

9601295

Address

1 Hikarigaoka Fukushima City, Fukushima

TEL

0245471342

Email

masui@fmu.ac.jp


Public contact

Name of contact person

1st name Shinju
Middle name
Last name Obara

Organization

Fukushima Medical University

Division name

Surgical Operation Department

Zip code

9601295

Address

1 Hikarigaoka Fukushima City, Fukushima

TEL

0245471342

Homepage URL


Email

masui@fmu.ac.jp


Sponsor or person

Institute

Fukushima Medical University

Institute

Department

Personal name



Funding Source

Organization

Fukushima Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima Medical University Research Ethics Committee

Address

1 Hikarigaoka, Fukushima City, Fukushima, JAPAN

Tel

0245471825

Email

rs@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 05 Day


Related information

URL releasing protocol

https://www.minervamedica.it/en/journals/minerva-anestesiologica/article.php?cod=R02Y2021N07A0774

Publication of results

Partially published


Result

URL related to results and publications

https://www.minervamedica.it/en/journals/minerva-anestesiologica/article.php?cod=R02Y2021N07A0774

Number of participants that the trial has enrolled

36

Results

Compared to the old algorithm group, the incidence of abnormally high PSi values (AHPSi ) was significantly lower in the updated algorithm group (26.7% vs. 4.2%, P<0.001). Lower TP values and the use of the old algorithm have significant effect on increased PSi values (P<0.001).

Results date posted

2021 Year 11 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 05 Month 03 Day

Baseline Characteristics

36 elderly patients (60-85 years of age) with American Society of Anesthesiologists (ASA ) physical status of I or II who were scheduled for elective surgery

Participant flow

Using a computer-generated table of random numbers, patients were randomly allocated to two groups: a group to be assessed with the older version of the SedLine sensor and a group to be evaluated with the updated SedLine sensor.

Adverse events

None

Outcome measures

abnormally high PSi values (AHPSi).

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 06 Month 04 Day

Date of IRB

2017 Year 05 Month 30 Day

Anticipated trial start date

2017 Year 06 Month 05 Day

Last follow-up date

2019 Year 02 Month 04 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 04 Day

Last modified on

2021 Year 11 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031656


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name